Vaccine effectiveness against COVID-19: A test negative case-control study in Tunisia, August 2021
Author:
Mziou EmnaORCID,
Hchaichi Aicha,
Letaief Hejer,
Dhaouadi Sonia,
Safer Mouna,
Talmoudi Khouloud,
Mhadhbi Rim,
Elmili Nawel,
Bouabid Leila,
Derouiche Sondes,
Bougatef Souha,
Bellali HediaORCID,
Bouafif ép Ben Alaya Nissaf
Reference20 articles.
1. Is the COVID-19 vaccine effective on the US financial market?;Khalfaoui;Public Health,2021
2. The socio-economic implications of the coronavirus pandemic (COVID-19): a review;Nicola;Int J Surg,2020
3. The role of good governance in the race for global vaccination during the COVID-19 pandemic;Tatar;Sci Rep,2021
4. Progress of the COVID-19 Vaccine Effort: Viruses, Vaccines and Variants versus Efficacy. Effectiveness and Escape;Tregoning;Nat Rev Immunol,2021
5. Florentino PTV, Millington T, Cerqueira-Silva T, Robertson C, Oliveira V de A, et al. Vaccine Effectiveness of Two-Dose BNT162b2 against Symptomatic and Severe COVID-19 among Adolescents in Brazil and Scotland over Time: A Test-Negative Case-Control Study. The Lancet Infectious Diseases, doi:10.1016/S1473-3099(22)00451-0.